Anxo Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	363.37	358.92	295.43	241.32	214.18
Short-Term Investments	-	2.23	89.75	-	-
Cash & Short-Term Investments	363.37	361.14	385.18	241.32	214.18
Cash Growth	0.62%	-6.24%	59.61%	12.67%	3.09%
Accounts Receivable	178.62	210.5	249.71	240.86	208.64
Other Receivables	9.05	4.67	11.36	10.63	10.42
Receivables	187.67	215.17	261.07	251.49	219.07
Inventory	253.82	262.42	283.86	243.1	238.88
Prepaid Expenses	18.92	18.15	22.19	14.88	17.11
Other Current Assets	24.16	21.69	25.99	20.7	15.54
Total Current Assets	847.94	878.56	978.29	771.5	704.78
Property, Plant & Equipment	1,022	1,038	1,079	1,110	1,140
Long-Term Investments	57.78	52.56	30	-	-
Goodwill	36.61	36.61	36.61	36.61	36.61
Other Intangible Assets	7.86	9.84	3.77	4.95	4.3
Long-Term Deferred Tax Assets	44.22	34.38	22.03	18.75	11.77
Other Long-Term Assets	50.42	57.8	68.82	32.79	21.81
Total Assets	2,067	2,108	2,219	1,974	1,919
Accounts Payable	64.95	81.55	79.69	94.03	78.43
Accrued Expenses	83.05	88.43	75.35	71.58	66.73
Short-Term Debt	268	205	215	256.38	215
Current Portion of Long-Term Debt	58.6	63.46	58.5	57.55	64.68
Current Portion of Leases	13.62	9.36	14.65	11.5	8.69
Current Income Taxes Payable	-	-	6.68	6.76	4.33
Current Unearned Revenue	21.6	20.07	5.43	14.47	5.04
Other Current Liabilities	29.67	34.76	31.42	42.8	29.95
Total Current Liabilities	539.48	502.61	486.72	555.07	472.84
Long-Term Debt	388.8	437.61	480.7	528.08	572.61
Long-Term Leases	5.95	11.2	19	33.57	21.49
Long-Term Unearned Revenue	16.4	16.21	27.73	26.49	18.09
Long-Term Deferred Tax Liabilities	0.16	-	-	-	-
Other Long-Term Liabilities	7.91	0.58	1.19	1.26	2.02
Total Liabilities	958.7	968.21	1,015	1,144	1,087
Common Stock	558.71	558.14	556.64	481.64	481.64
Additional Paid-In Capital	459.35	483.68	478.85	211.08	206.62
Retained Earnings	-34.13	-25.46	54.01	32.14	44.7
Comprehensive Income & Other	7.83	6	-	-	-
Total Common Equity	991.76	1,022	1,089	724.86	732.96
Minority Interest	116.37	117	113.76	104.78	98.99
Shareholders' Equity	1,108	1,139	1,203	829.64	831.94
Total Liabilities & Equity	2,067	2,108	2,219	1,974	1,919
Total Debt	734.97	726.63	787.84	887.09	882.47
Net Cash (Debt)	-371.6	-365.49	-402.66	-645.76	-668.29
Net Cash Per Share	-6.65	-6.56	-7.81	-13.41	-13.78
Filing Date Shares Outstanding	55.87	55.81	55.66	48.16	48.16
Total Common Shares Outstanding	55.87	55.81	55.66	48.16	48.16
Working Capital	308.45	375.94	491.57	216.43	231.93
Book Value Per Share	17.75	18.32	19.57	15.05	15.22
Tangible Book Value	947.28	975.92	1,049	683.3	692.04
Tangible Book Value Per Share	16.95	17.49	18.85	14.19	14.37
Land	576.53	576.53	576.53	576.53	576.53
Buildings	423.96	417.99	417.99	416.05	417.89
Machinery	501.41	463.03	464.55	434.6	436.82
Construction In Progress	5.91	9.88	-	-	-
Leasehold Improvements	14.5	15.9	3.99	2.02	10.09